Sphera Funds Management Ltd. Uro Gen Pharma Ltd. Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$21.11 - $34.86 $7.09 Million - $11.7 Million	-335,817 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $653,895 - $999,913	27,440 Added 8.9%	335,817 $8 Million
Q1 2019 May 15, 2019	BUY	$35.47 - $54.55 $10.9 Million - $16.8 Million	308,377 New	308,377 $11.4 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $271M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.